|
|
Lieferanten für
Calenduloside e
|
|
1 Registerierte Lieferanten
Description: Calenduloside E exhibits hypoglycemic activity by suppressing the transfer of glucose from the stomach to the small intestine and by inhibiting glucose transport at the brush border of the small intestine in oral glucose-loaded rats. - Molecular Weight:632.835
- Purity:>98%
Molecular Formula: C36H56O9 Canonical SMILES: CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)OC6C(C(C(C(O6)C(=O)O)O)O)O)C)C)C2C1)C)C(=O)O)C InChI: InChI=1S/C36H56O9/c1-31(2)14-16-36(30(42)43)17-15-34(6)19(20(36)18-31)8-9-22-33(5)12-11-23(32(3,4)21(33)10-13-35(22,34)7)44-29-26(39)24(37)25(38)27(45-29)28(40)41/h8,20-27,29,37-39H,9-18H2,1-7H3,(H,40,41)(H,42,43)/t20-,21-,22+,23-,24-,25-,26+,27-,29+,33-,34+,35+,36-/m0/s1 InChIKey: IUCHKMAZAWJNBJ-RCYXVVTDSA-N Solubility: Soluble in DMSO Synonyms: Silphioside F; Glycoside St-E; Polysciasaponin P7; Momordin Ib; (4bS,5R,10bS,11R)-5,6,11,12-Tetrahydro-13,18-dimethyl-5,10b:11,4b-Bis(iminoethano)dibenzo[c,h][2,6]naphthyridine; (+)-Calycanthine; 5,6,11,12-tetrahydro-13,18-dimethyl-, [4bS-(4bα,5α,10bα,11α)]-5,10b:11,4b-Bis(iminoethano)dibenzo[c,h][2,6]naphthyridine; NSC 99016; [4bS-(4bα,5α,10bα,11α)]-5,6,11,12-Tetrahydro-13,18-dimethyl-5,10b:11,4b-bis(iminoethano)dibenzo[c,h][2,6]naphthyridine; d-Calycanthine Weitere Informationen finden Sie hier
|
|
|
Privilegierte Lieferanten
Letztes Update 2024-06-26
|